FDA Drug Application (020500) for MEPRON by GLAXOSMITHKLINE LLC

Back to FDA Applications sponsored by GLAXOSMITHKLINE LLC

Application Number020500
Product Number001
FormSUSPENSION;ORAL
Dosage750MG/5ML
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameMEPRON
Active IngredientATOVAQUONE



Back to FDA Applications sponsored by GLAXOSMITHKLINE LLC

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.